4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-001153
Director sold 62,590 shares at $8.01 ($501,346)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Gautam Director | 2025-01-08 | Sale 10b5-1 | −62,590 | $8.01 | $501,346 | 1,968,886 | D |
| Open-market sales · 62,590 sh · avg $8.01 · $501,346 | |||||||
Loading xslF345X05/wk-form4_1736544318.xml…